April 01, 1997; 48 (Suppl 5) Articles
The clinical limits of myasthenia gravis and differential diagnosis
Robert P. Lisak
First published April 1, 1997, DOI: https://doi.org/10.1212/WNL.48.Suppl_5.36S
The clinical limits of myasthenia gravis and differential diagnosis
Robert P. Lisak
Neurology Apr 1997, 48 (Suppl 5) 36S-39S; DOI: 10.1212/WNL.48.Suppl_5.36S
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 48 no. Suppl 5 36S-39S
Print ISSN:
Online ISSN:
History:
- First Published April 1, 1997.
Copyright & Usage:
Copyright 1997 by Advanstar Communications Inc.
Author Disclosures
- Robert P. Lisak, MD
- Robert P. Lisak, MD
- From the Departments of Neurology and Immunology and Microbiology, Wayne State University School of Medicine, University Health Center, Detroit, MI.
- Address correspondence and reprint requests to Dr. Robert P. Lisak, Departments of Neurology and Immunology and Microbiology, Wayne State University School of Medicine, 6E-University Health Center, 4201 St. Antoine, Detroit, MI 48201.
Article usage
Letters: Rapid online correspondence
No comments have been published for this article.
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Dr. Ann Yeh and Dr. Daniela Castillo Villagrán
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Expedited Publication
Antibody to acetylcholine receptor in myasthenia gravisPrevalence, clinical correlates, and diagnostic valueJON M. LINDSTROM, MARJORIE E. SEYBOLD, VANDA A. LENNON et al.Neurology, October 01, 1998 -
Article
High κ free light chain is a potential biomarker for double seronegative and ocular myasthenia gravisAdi Wilf-Yarkoni, Yifat Alkalay, Talma Brenner et al.Neurology: Neuroimmunology & Neuroinflammation, July 14, 2020 -
Introduction
Myasthenia gravisHistorical perspective and overviewDavid S. Younger, Bradford B. Worrall, Audrey S. Penn et al.Neurology, April 01, 1997 -
Articles
Serologic profile of myasthenia gravis and distinction from the Lambert-Eaton myasthenic syndromeVanda A. Lennon et al.Neurology, April 01, 1997